Adherence
Specialty Treatments Require a New Approach to Affordability
As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an ...
GoodRx Surpasses $500M in Savings for Americans with Diabetes
First, some good news about diabetes. GoodRx is a leading resource for people with ...
Avoid the Narrow Framing Trap—Take a More Empathetic Approach to Medication Adherence
Is it enough to think that we can simply “nudge” patients into adherence? While ...
Addressing the Polypharmacy Problem
Many of us have someone in our life—a parent, a spouse, or loved one—who ...
Less Is More—A Sharper Focus on Patient Needs Improves Adherence
“Drugs don’t work in patients who don’t take them,” C. Everett Koop, MD, U.S. ...
Putting the Patient at the Top of Your Adherence Approach
“People adhere to medicines at a scale that should bewilder everyone in healthcare,” exclaims ...
Two Key Questions About Adherence/Compliance in 2023
PM360 asked experts in helping patients stay on their prescribed therapies about where the ...
12 New Ways Companies Are Helping to Improve Adherence
PM360 asked for companies to send in their latest and best ways to improve ...
Tackling the 3 Leading Causes of Nonadherence: Fear, Cost, and Misunderstanding
Medication nonadherence costs the U.S. pharmaceutical industry an estimated $250 billion annually in potential ...
PM360 Circle of Excellence: The Barriers to Adherence—Solvable or Insurmountable?
On September 21, 2022, we gathered our 2022 Trailblazer Brand Champions for a roundtable ...
Visualizing New Data Stories Helps Pharma Smooth Gaps in the Patient Journey
Harnessing data to present a holistic view of a patient’s individual journey can transform ...
End-to-End Patient Engagement is the Key to Improving Adherence
Although great strides have been made in the development of new medications for so ...
Adherence to Treatment: Making the Most of the First 30 Days
Medication non-adherence has a staggering impact on the industry’s ability to serve patient well-being ...
